Kelly Smales - Jan 20, 2024 Form 4 Insider Report for Transphorm, Inc. (TGAN)

Role
Director
Signature
/s/ Cameron McAulay, Attorney-in-Fact
Stock symbol
TGAN
Transactions as of
Jan 20, 2024
Transactions value $
$0
Form type
4
Date filed
1/23/2024, 04:35 PM
Previous filing
Jan 5, 2024
Next filing
Jan 26, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TGAN Common Stock Award $0 +1.35K +1.75% $0.00 78K Jan 20, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share is represented by a Restricted Stock Unit ("RSU") that was fully vested as of the grant date. The RSUs were automatically granted to the Reporting Person pursuant to the Issuer's Outside Director Compensation Policy in lieu of cash fees for service during the quarter ended December 31, 2023.